Determination of Insulin Resistance Using the Homeostatic Model Assessment (HOMA) and its Relation With the Risk of Developing Pregnancy-Induced Hypertension

American Journal of Hypertension

Volumn 20, Issue 4, 2007, Pages 437-442

  Sierra Laguado, Jesús ^a   García, Ronald G ^a   Celedón, Johanna ^a   Arenas Mantilla, Mario ^a   Pradilla, Lina P ^a   Camacho, Paul A ^a   López Jaramillo, Patricio ^a  

^a Cardiovascular Foundation of Colombia   (Colombia)

Author keywords

HOMA; insulin resistance; metabolic syndrome; Pregnancy induced hypertension

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL ASSESSMENT TOOL; COLOMBIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL ASSESSMENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COHORT STUDIES; COLOMBIA; FEMALE; HOMEOSTASIS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INSULIN; INSULIN RESISTANCE; MODELS, THEORETICAL; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33947331366     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.10.009     Document Type: Article

References (29)

1. Walker J.J. Pre-eclampsia. Lancet 356 (2000) 1260-1265
2. Ministerio de Protección Social, INS, and OPS: Situación de salud en Colombia: Indicadores básicos (2003), Ministerio de Protección Social, INS, and OPS, Bogotá, Columbia
3. Lopez-Jaramillo P., Garcia R.G., and Lopez M. Preventing pregnancy-induced hypertension: are there regional differences for this global problem?. J Hypertens 23 (2005) 1121-1129
4. Fruchart J.C., Nierman M.C., Stroes E.S., Kastelein J.J., and Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 109 (2004) III15-III19
5. Wolf M., Hubel C.A., Lam C., Sampson M., Ecker J.L., Ness R.B., Rajakumar A., Daftary A., Shakir A.S., Seely E.W., Roberts J.M., Sukhatme V.P., Karumanchi S.A., and Thadhani R. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 89 (2004) 6239-6243
6. Catalano P.M., Tyzbir E.D., Roman N.M., Amini S.B., and Sims E.A. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 165 (1991) 1667-1672
7. Kaaja R., Laivuori H., Laakso M., Tikkanen M.J., and Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 48 (1999) 892-896
8. O'Brien T.E., Ray J.G., and Chan W.S. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14 (2003) 368-374
9. Wolf M., Sandler L., Munoz K., Hsu K., Ecker J.L., and Thadhani R. First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 87 (2002) 1563-1568
10. Kaaja R., Laivuori H., Pulkki P., Tikkanen M.J., Hiilesmaa V., and Ylikorkala O. Is there any link between insulin resistance and inflammation in established preeclampsia?. Metabolism 53 (2004) 1433-1435
11. Salamalekis E., Vitoratos N., Makrakis E., Mastorakos G., Eleftheriadis M., and Creatsas G. No association between insulin resistance and preeclampsia. J Matern Fetal Neonatal Med 18 (2005) 113-115
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
13. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., Monauni T., and Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23 (2000) 57-63
14. National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
15. Solomon C.G., and Seely E.W. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome?. Hypertension 37 (2001) 232-239
16. Romero-Gutiérrez G., Alvarez Cisneros J.A., and Ponce de Leon A.L. Association between insulin resistance and pregnancy-induced hypertension. Case-control study. Ginecol Obstet Mex 71 (2003) 244-252
17. Romero-Gutiérrez G., Malacara J.M., Amador N., Fierro-Martinez C., Munoz-Guevara L.M., and Molina-Rodriguez R. Homeostatic model assessment and risk for hypertension during pregnancy: a longitudinal prospective study. Am J Perinatol 21 (2004) 455-462
18. Kocyigit Y., Bayhan G., Atamer A., and Atamer Y. Serum levels of leptin, insulin-like growth factor-I and insulin-like growth factor binding protein-3 in women with pre-eclampsia, and their relationship to insulin resistance. Gynecol Endocrinol 18 (2004) 341-348
19. Weisz B., Cohen O., Homko C.J., Schiff E., and Sivan E. Elevated serum uric acid levels in gestational hypertension are correlated with insulin resistance. Am J Perinatol 22 (2005) 139-144
20. Parretti E., Lapolla A., Dalfra M., Pacini G., Cioni R., Marzari C., Scarselli G., and Mello G. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 47 (2006) 449-453
21. Solomon C.G., Carroll J.S., Okamura K., Graves S.W., and Seely E.W. Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens 12 (1999) 276-282
22. Enquobahrie D.A., Williams M.A., Butler C.L., Frederick I.O., Miller R.S., and Luthy D.A. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 17 (2004) 574-581
23. Arcaro G., Cretti A., Balzano S., Lechi A., Muggeo M., Bonora E., and Bonadonna R.C. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 105 (2002) 576-582
24. Conde-Agudelo A., and Belizan J.M. Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women. BJOG 107 (2000) 75-83
25. Brook R.D., Bard R.L., Rubenfire M., Ridker P.M., and Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 88 (2001) 1264-1269
26. de Frutos T., de Miguel L.S., Garcia-Duran M., Gonzalez-Fernandez F., Rodriguez-Feo J.A., Monton M., Guerra J., Farre J., Casado S., and Lopez-Farre A. NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-alpha. Am J Physiol 277 (1999) H317-H1325
27. Teran E., Escudero C., Moya W., Flores M., Vallance P., and Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet 75 (2001) 243-249
28. Bautista L.E., Lopez-Jaramillo P., Vera L.M., Casas J.P., Otero A.P., and Guaracao A.I. Is C-reactive protein an independent risk factor for essential hypertension?. J Hypertens 19 (2001) 857-861
29. Garcia RG, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F, Arenas-Mantilla M, Lopez-Jaramillo P: Raised C-reactive protein and impaired flow mediated vasodilation precede the development of preeclampsia. Am J Hypertens (in press).